Clendon Biotech Capital | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,087 results for “Clendon Biotech Capital”

Trials

View all 1310 →

Post-Procedural Biotech Cellulose Mask

15 participants · First posted Oct 3, 2023

Provigil (Modafinil) Study by Taiwan Biotech Co.

30 participants · First posted Sep 15, 2005

Not yet recruiting

PACTR201806003389716

Capital Mãe

446 participants

Drugs

View all 834 →

PAD4 inhibitors(Capital Medical University)

IGC-AD1

Somatropin biosimilar(AMEGA Biotech)

Organizations

View all 421 →

Hercules Capital

United States

Rand Capital

Associated Capital

United States

News

View all 5522 →

InhaleRx Secures Funding for Phase 2 Trials of IRX-211 in Breakthrough Cancer Pain

InhaleRx Secures $38.5M Funding to Advance Inhaled Therapies for Cancer Pain and Panic Disorder

InhaleRx Secures $38.5 Million Funding to Advance Novel Inhaled Therapies for Cancer Pain and Panic Disorder

Page 1 of 809